PTJ Author Interview: Randomized Clinical Trials and Real-World Practice

PTJ Author Interview: Randomized Clinical Tri...

Up next

What to Know About the New Code of Ethics for the Physical Therapy Profession

In this episode, ethics experts discuss the development of the Code of Ethics for the Physical Therapy Profession, which went into effect Jan. 1, 2026. Members of the APTA Ethics and Judicial Committee and the Ethics Task Force break down what the code means for both everyday pra ...  Show more

PTJ Author Interview: PT-Administered Physical Activity After Knee Replacement

In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Daniel White, PT, ScD, MSc, about his recently published survey study, which evaluated the effectiveness of a physical therapist-administered physical activity intervention in increasing ...  Show more

Recommended Episodes

Older Patients With NSTEMI Randomized Interventional Treatment: SENIOR-RITA Trial
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

<div class="OutlineElement Ltr SCXW252216131 BCX0">

<span class= "TextRun SCXW252216131 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW252216131 BCX0">The goal of the</span> <span class="NormalTextR ...

  Show more

"The Problem with Clinical Trials" with Jonathan Shedler, Ph.D. - s1, e10
Making Therapy Better

Jonathan Shedler, Phd is a clinical professor of psychiatry at the University of California, San Francisco (UCSF) and faculty member at the San Francisco Center for Psychoanalysis. He is author of numerous scientific and scholarly articles, and his article The Efficacy of Psyc ...

  Show more

#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group
Core IM | Internal Medicine Podcast

How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still neede ...  Show more

WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

<div class="OutlineElement Ltr SCXW195419042 BCX0">

<span class= "TextRun SCXW195419042 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class= "NormalTextRun SCXW195419042 BCX0">Funded by the Congressionally Directed Medical ...

  Show more